What was filed
Jagsonpal Pharmaceuticals has told BSE and NSE that its Board of Directors will meet on Wednesday, 29 July 2026 to consider and approve, inter alia, the unaudited financial results for the quarter ended 30 June 2026. The intimation was made under Regulation 29 of the SEBI (LODR) Regulations, 2015, which requires prior notice of board meetings at which financial results are taken up.
Trading window
In continuation of its earlier letter dated 26 June 2026, the company reiterated that the trading window for dealing in its securities remains closed until 31 July 2026 — a routine restriction tied to the results process. The intimation carries no financial figures; the quarterly numbers will follow the board meeting.